Trial no.:
|
PACTR202405467152740 |
Date of Approval:
|
13/05/2024 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
The effect of ultrasound guided Pecto-Intercostal Fascial Plane Block with Levobupivacaine on extubation time after On Pump Coronary Artery Bypass Grafting surgery |
Official scientific title |
The effect of ultrasound guided Pecto-Intercostal Fascial Plane Block with Levobupivacaine on extubation time after On Pump Coronary Artery Bypass Grafting surgery: A randomized control trial |
Brief summary describing the background
and objectives of the trial
|
Coronary artery bypass grafting (CABG) is considered the gold standard for coronary revascularization. Preventive measures for postoperative pain are always sought to avoid its adverse consequences, the most critical of which are respiratory complications in the form of atelectasis, hypoxemia and pneumonia. It has been found that the worst pain after cardiac surgery is experienced within the first 4 postoperative days, being moderate at rest but severe with coughing or movement. The sensory innervation of the chest wall is derived from the perforating branches of the intercostal nerves, and it is inevitably disturbed during sternotomy in cardiac surgery, causing the consequences of nerve injury pain. Acute postoperative pain is also a predictive risk for chronic pain, and peripheral and central pain sensitization often follows tissue injury. The risk of chronic post surgical pain (CPSP) was found to be directly proportional to the duration of severe postoperative pain. In addition, patients who require ICU stay for more than 48 hours after cardiac surgery have higher in-hospital mortality, lower long-term survival, and higher risk of hospital readmission for cardiac events. Recently, many enhanced recovery after surgery (ERAS) protocols have been applied in cardiac surgery, and in addition to pain control, they include early extubation approach and seem to have good success in reducing time to extubation, ICU length of stay (LOS), hospital LOS, and thus overall costs. They include using a multimodal analgesia approach to reduce the side effects of using opioids as the sole agent, thus preventing the so-called opioid-related adverse drug events. The most serious of these is respiratory depression. Previous studies investigating the effect of pecto-intercostal fascial plane block on postoperative pain in the cardiac surgery population did not consider the effect on extubation time as their primary outcome and were therefore underpowered to correlate between this type |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Supportive care |
Anticipated trial start date |
21/10/2021 |
Actual trial start date |
21/10/2021 |
Anticipated date of last follow up |
31/10/2022 |
Actual Last follow-up date |
31/10/2022 |
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|